Dynavax Technologies
DVAX
#5098
Rank
NZ$3.23 B
Marketcap
NZ$27.57
Share price
0.00%
Change (1 day)
13.20%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.94 Billion

According to Dynavax Technologies 's latest financial reports the company has NZ$0.94 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$1.05 B7.58%
2023-12-31$NZ$0.98 B7.49%
2022-12-31$NZ$0.91 B181.09%
2021-12-31$NZ$0.32 B300.23%
2020-12-31$NZ$81.34 M560.84%
2019-12-31$NZ$12.3 M-86.91%
2018-12-31$NZ$94.01 M-66.54%
2017-12-31$NZ$0.28 B118.19%
2016-12-31$NZ$0.12 B-52.89%
2015-12-31$NZ$0.27 B113.14%
2014-12-31$NZ$0.12 B-43.43%
2013-12-31$NZ$0.22 B62.41%
2012-12-31$NZ$0.13 B9.07%
2011-12-31$NZ$0.12 B89.46%
2010-12-31$NZ$67.54 M669.45%
2009-12-31$NZ$8.77 M-68.47%
2008-12-31$NZ$27.84 M-45.5%
2007-12-31$NZ$51.08 M-54.48%
2006-12-31$NZ$0.11 B3.16%
2005-12-31$NZ$0.10 B29.66%
2004-12-31$NZ$83.91 M-195.36%
2003-12-31$-NZ$88 Million-18.31%
2002-12-31$-NZ$0.11 Billion29.96%
2001-12-31$-NZ$82.89 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$152.04 B 15,905.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.78 B 2,088.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$33.52 B 3,428.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$20.88 B 2,098.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$74.66 B 7,760.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$89.58 B 9,330.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$40.47 B 4,161.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
-NZ$0.37 Billion-138.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$13.79 B 1,352.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel